Neuroone Medical Technologies (NMTC) Total Liabilities (2010 - 2026)

Neuroone Medical Technologies (NMTC) has reported Total Liabilities for 17 consecutive years, with $2.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Liabilities fell 8.46% year-over-year to $2.4 million; the trailing twelve-month figure through Jun 2026 stood at $2.4 million (down 8.46% YoY), and the FY2025 full-year result was $3.7 million, down 18.36% from the prior year.
• Total Liabilities slipped to $2.4 million in Q2 2026 per NMTC's latest filing, from $2.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $4.5 million in Q3 2024 and bottomed at $952478.0 in Q2 2022.
• Historically, Total Liabilities has averaged $2.3 million across 5 years, with a median of $2.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities plunged 42.58% in 2023, then surged 153.46% in 2024.
• Over 5 years, Total Liabilities stood at $1.5 million in 2022, then dropped by 5.66% to $1.4 million in 2023, then soared by 153.46% to $3.6 million in 2024, then tumbled by 38.87% to $2.2 million in 2025, then gained by 11.16% to $2.4 million in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $2.4 million, $2.5 million, and $2.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.